AOBiome

Last updated
AOBiome
Type of business Private
Founded2013
Headquarters,
United States
Key peopleLenny Barshack
James Heywood
Hilly Thompson
David Whitlock
URL www.aobiome.com
Current statusActive

AOBiome is a Boston-based biotech company focused on transforming human health through products that restore ammonia-oxidizing bacteria (AOB). The company is developing a novel class of therapeutics to improve skin health, hypertension, and other systemic conditions.

Contents

Company

The company was founded in 2013 by MIT chemical engineer David Whitlock and PatientsLikeMe founder Jamie Heywood, along with co-founders Hilly Thompson and Lenny Barshack.

History

In 2001 while on a date near some horse stables, engineer David Whitlock was asked why horses roll in the dirt. [1] Not knowing the answer, he studied soil samples and hypothesized that the Nitrosomonas eutropha that he found present was a key species as these bacteria feed on ammonia and thus could provide a symbiotic ammonia processing function for horses and other vertebrates. To test this theory he suspended the bacteria in water and coated himself with them and then stopped bathing in order to give the AOB a chance to colonize his body. Whitlock has reported in national media that he has not had a shower in over 10 years, but washes his hands before eating, [2] with a number of journalists confirming that he does not smell bad as a result. [3] Whitlock has speculated, along the lines of the “hygiene hypothesis”, that modern lifestyle changes such as the adoption of frequent bathing and synthetic cosmetics have led to the death of so-called “old friend” bacteria which previously performed important functions in the body. [4]

AOBiome was founded in 2013 with a mission to study the effects of AOB on the skin microbiome and overall skin health. They have since performed in-vitro studies, in-vivo studies, and two human studies in acne vulgaris, the results of which have led the company to now additionally explore systemic therapies for conditions such as hypertension. [5] [6] [7] [8] The company has a patent covering the topical use of AOB. [9]

Ammonia-oxidizing bacteria

Ammonia-oxidizing bacteria (AOB) are a naturally occurring type of nitrifying bacteria that metabolize the ammonia found in sweat, creating nitrite and nitric oxide. [10] AOBiome is testing the hypothesis that by increasing local and systemic nitric oxide levels, this bacteria has both anti-inflammatory and anti-infective properties. [11] While the therapeutic potential of nitrite and nitric oxide is widely recognized, the bacteria are sensitive to the ingredients in most modern soaps and beauty products. AOBiome's cosmetic partner Mother Dirt is therefore the first skincare company to formulate products that support the growth of healthy bacteria.

Clinical trials

AOBiome is developing topical biologics for the treatment of inflammatory conditions, specifically looking at the therapeutic properties of ammonia-oxidizing bacteria. AOBiome started its Phase 2 clinical trial for adult acne in 2015. AOBiome has received attention for its prospective interventional study on the link between a bacteria-infused topical spray and hypertension. The Wall Street Journal describes that “Although the company knew when it began work on treating acne that nitric oxide has a beneficial effect on hypertension, it didn’t expect to see such a strong reduction of blood pressure in the [acne] study.” [12]

They are also looking into related therapies for allergic rhinitis and eczema (Phase I trials) as well as wound healing, migraines, and thermoregulation (preclinical trials).

Related Research Articles

<span class="mw-page-title-main">Acne</span> Skin condition characterized by pimples

Acne, also known as acne vulgaris, is a long-term skin condition that occurs when dead skin cells and oil from the skin clog hair follicles. Typical features of the condition include blackheads or whiteheads, pimples, oily skin, and possible scarring. It primarily affects skin with a relatively high number of oil glands, including the face, upper part of the chest, and back. The resulting appearance can lead to lack of confidence, anxiety, reduced self-esteem, and, in extreme cases, depression or thoughts of suicide.

<span class="mw-page-title-main">Minocycline</span> Chemical compound

Minocycline, sold under the brand name Minocin among others, is a tetracycline antibiotic medication used to treat a number of bacterial infections such as pneumonia. It is generally less preferred than the tetracycline doxycycline. Minocycline is also used for the treatment of acne and rheumatoid arthritis. It is taken by mouth or applied to the skin.

<span class="mw-page-title-main">Nitrification</span> Biological oxidation of ammonia/ammonium to nitrate

Nitrification is the biological oxidation of ammonia to nitrite followed by the oxidation of the nitrite to nitrate occurring through separate organisms or direct ammonia oxidation to nitrate in comammox bacteria. The transformation of ammonia to nitrite is usually the rate limiting step of nitrification. Nitrification is an important step in the nitrogen cycle in soil. Nitrification is an aerobic process performed by small groups of autotrophic bacteria and archaea.

The nitrite ion has the chemical formula NO
2
. Nitrite is widely used throughout chemical and pharmaceutical industries. The nitrite anion is a pervasive intermediate in the nitrogen cycle in nature. The name nitrite also refers to organic compounds having the –ONO group, which are esters of nitrous acid.

<span class="mw-page-title-main">Tretinoin</span> Medication used for the treatment of acne and acute promyelocytic leukemia

Tretinoin, also known as all-trans retinoic acid (ATRA), is a medication used for the treatment of acne and acute promyelocytic leukemia. For acne, it is applied to the skin as a cream, gel or ointment. For leukemia, it is taken by mouth for up to three months. Topical tretinoin is also the most extensively investigated retinoid therapy for photoaging.

<span class="mw-page-title-main">Adapalene</span> Third-generation topical retinoid

Adapalene is a third-generation topical retinoid primarily used in the treatment of mild-moderate acne, and is also used off-label to treat keratosis pilaris as well as other skin conditions. Studies have found adapalene is as effective as other retinoids, while causing less irritation. It also has several advantages over other retinoids. The adapalene molecule is more stable compared to tretinoin and tazarotene, which leads to less concern for photodegradation. It is also chemically more stable compared to the other two retinoids, allowing it to be used in combination with benzoyl peroxide. Due to its effects on keratinocyte proliferation and differentiation, adapalene is superior to tretinoin for the treatment of comedonal acne and is often used as a first-line agent. The Swiss company Galderma sells adapalene under the brand-name product Differin.

<span class="mw-page-title-main">Tetrahydrobiopterin</span> Chemical compound

Tetrahydrobiopterin (BH4, THB), also known as sapropterin (INN), is a cofactor of the three aromatic amino acid hydroxylase enzymes, used in the degradation of amino acid phenylalanine and in the biosynthesis of the neurotransmitters serotonin (5-hydroxytryptamine, 5-HT), melatonin, dopamine, norepinephrine (noradrenaline), epinephrine (adrenaline), and is a cofactor for the production of nitric oxide (NO) by the nitric oxide synthases. Chemically, its structure is that of a (dihydropteridine reductase) reduced pteridine derivative (quinonoid dihydrobiopterin).

Nitrosomonas europaea is a Gram-negative obligate chemolithoautotroph that can derive all its energy and reductant for growth from the oxidation of ammonia to nitrite and lives in several places such as soil, sewage, freshwater, the walls of buildings and on the surface of monuments especially in polluted areas where the air contains high levels of nitrogen compounds.

<i>Nitrosomonas</i> Genus of bacteria

Nitrosomonas is a genus of Gram-negative bacteria, belonging to the Betaproteobacteria. It is one of the five genera of ammonia-oxidizing bacteria and, as an obligate chemolithoautotroph, uses ammonia as an energy source and carbon dioxide as a carbon source in presence of oxygen. Nitrosomonas are important in the global biogeochemical nitrogen cycle, since they increase the bioavailability of nitrogen to plants and in the denitrification, which is important for the release of nitrous oxide, a powerful greenhouse gas. This microbe is photophobic, and usually generate a biofilm matrix, or form clumps with other microbes, to avoid light. Nitrosomonas can be divided into six lineages: the first one includes the species Nitrosomonas europea, Nitrosomonas eutropha, Nitrosomonas halophila, and Nitrosomonas mobilis. The second lineage presents the species Nitrosomonas communis, N. sp. I and N. sp. II, meanwhile the third lineage includes only Nitrosomonas nitrosa. The fourth lineage includes the species Nitrosomonas ureae and Nitrosomonas oligotropha and the fifth and sixth lineages include the species Nitrosomonas marina, N. sp. III, Nitrosomonas estuarii and Nitrosomonas cryotolerans.

Denitrifying bacteria are a diverse group of bacteria that encompass many different phyla. This group of bacteria, together with denitrifying fungi and archaea, is capable of performing denitrification as part of the nitrogen cycle. Denitrification is performed by a variety of denitrifying bacteria that are widely distributed in soils and sediments and that use oxidized nitrogen compounds in absence of oxygen as a terminal electron acceptor. They metabolise nitrogenous compounds using various enzymes, turning nitrogen oxides back to nitrogen gas or nitrous oxide.

<i>Nitrobacter</i> Genus of bacteria

Nitrobacter is a genus comprising rod-shaped, gram-negative, and chemoautotrophic bacteria. The name Nitrobacter derives from the Latin neuter gender noun nitrum, nitri, alkalis; the Ancient Greek noun βακτηρία, βακτηρίᾱς, rod. They are non-motile and reproduce via budding or binary fission. Nitrobacter cells are obligate aerobes and have a doubling time of about 13 hours.

<span class="mw-page-title-main">Clindamycin/benzoyl peroxide</span> Type of medication

Clindamycin/benzoyl peroxide is a topical gel used for the treatment of acne. It is a fixed-dose combination of clindamycin, as the phosphate, an antibiotic, and benzoyl peroxide, an antiseptic.

Nitrifying bacteria are chemolithotrophic organisms that include species of genera such as Nitrosomonas, Nitrosococcus, Nitrobacter, Nitrospina, Nitrospira and Nitrococcus. These bacteria get their energy from the oxidation of inorganic nitrogen compounds. Types include ammonia-oxidizing bacteria (AOB) and nitrite-oxidizing bacteria (NOB). Many species of nitrifying bacteria have complex internal membrane systems that are the location for key enzymes in nitrification: ammonia monooxygenase, hydroxylamine oxidoreductase, and nitrite oxidoreductase.

Nitrospira translate into “a nitrate spiral” is a genus of bacteria within the monophyletic clade of the Nitrospirota phylum. The first member of this genus was described 1986 by Watson et al. isolated from the Gulf of Maine. The bacterium was named Nitrospira marina. Populations were initially thought to be limited to marine ecosystems, but it was later discovered to be well-suited for numerous habitats, including activated sludge of wastewater treatment systems, natural biological marine settings, water circulation biofilters in aquarium tanks, terrestrial systems, fresh and salt water ecosystems, and hot springs. Nitrospira is a ubiquitous bacterium that plays a role in the nitrogen cycle by performing nitrite oxidation in the second step of nitrification. Nitrospira live in a wide array of environments including but not limited to, drinking water systems, waste treatment plants, rice paddies, forest soils, geothermal springs, and sponge tissue. Despite being abundant in many natural and engineered ecosystems Nitrospira are difficult to culture, so most knowledge of them is from molecular and genomic data. However, due to their difficulty to be cultivated in laboratory settings, the entire genome was only sequenced in one species, Nitrospira defluvii. In addition, Nitrospira bacteria's 16s rRNA sequences are too dissimilar to use for PCR primers, thus some members go unnoticed. In addition, members of Nitrospira with the capabilities to perform complete nitrification has also been discovered and cultivated.

Naproxcinod (nitronaproxen) is a nonsteroidal anti-inflammatory drug (NSAID) developed by the French pharmaceutical company NicOx. It is a derivative of naproxen with a nitroxybutyl ester to allow it to also act as a nitric oxide (NO) donor. This second mechanism of action makes naproxcinod the first in a new class of drugs, the cyclooxygenase inhibiting nitric oxide donators (CINODs), that are hoped to produce similar analgesic efficacy to traditional NSAIDs, but with less gastrointestinal and cardiovascular side effects.

<span class="mw-page-title-main">Riociguat</span> Chemical compound

Riociguat, sold under the brand name Adempas, is a medication by Bayer that is a stimulator of soluble guanylate cyclase (sGC). It is used to treat two forms of pulmonary hypertension (PH): chronic thromboembolic pulmonary hypertension (CTEPH) and pulmonary arterial hypertension (PAH). Riociguat constitutes the first drug of the class of sGC stimulators. The drug has a half-life of 12 hours and will decrease dyspnea associated with pulmonary arterial hypertension.

Ammonia monooxygenase (EC 1.14.99.39, AMO) is an enzyme, which catalyses the following chemical reaction

Nitrosomonas eutropha is an ammonia-oxidizing, Gram-negative bacterium from the genus of Nitrosomonas.

<span class="mw-page-title-main">Clascoterone</span> Chemical compound

Clascoterone, sold under the brand name Winlevi, is an antiandrogen medication which is used topically in the treatment of acne. It is also under development in a higher concentration for the treatment of androgen-dependent scalp hair loss, under the brand name Breezula. The medication is used as a cream by application to the skin, for instance the face and scalp.

Tretinoin/benzoyl peroxide, sold under the brand name Twyneo, is a fixed-dose combination medication used for the treatment of acne. It contains tretinoin, a vitamin A derivative, and benzoyl peroxide, an oxidizing agent.

References

  1. Scott, Julia (May 22, 2014). "My No-Soap, No-Shampoo, Bacteria-Rich Hygiene Experiment". The New York Times. ISSN   0362-4331 . Retrieved June 14, 2017.
  2. "No Shower, No Problem — Just Spritz With Bacteria". NPR.org. Retrieved June 14, 2017.
  3. "David Whitlock Hasn't Showered In 13 Years!". WGBH News. 2016-03-22. Retrieved June 14, 2017.
  4. Whitlock, David R.; Feelisch, Martin (2009). Rook, Graham A. W. (ed.). The Hygiene Hypothesis and Darwinian Medicine. Progress in Inflammation Research. Birkhäuser Basel. pp. 103–115. doi:10.1007/978-3-7643-8903-1_6. ISBN   9783764389024.
  5. Gormley, Brian (2016-12-15). "AOBiome Stumbles Upon Blood-Pressure Target After Starting on Acne". Wall Street Journal. ISSN   0099-9660 . Retrieved 2017-06-14.
  6. "A Prospective Study of B244 Delivered as a Topical Spray to Determine Safety and Efficacy in Subjects With Elevated Blood Pressure - Full Text View - ClinicalTrials.gov". clinicaltrials.gov. Retrieved 2017-06-14.
  7. "Clinical Trial in Subjects With Mild to Moderate Acne Vulgaris - Full Text View - ClinicalTrials.gov". clinicaltrials.gov. Retrieved 2017-06-14.
  8. "A Double Blind, Placebo-Controlled, Randomized Study in Subjects With Acne Vulgaris - Full Text View - ClinicalTrials.gov". clinicaltrials.gov. 3 April 2017. Retrieved 2017-06-14.
  9. "Compositions including ammonia oxidizing bacteria to increase production of nitric oxide and nitric oxide precursors and methods of using same". 2001-08-10.{{cite journal}}: Cite journal requires |journal= (help)
  10. Jones, Mitchell Lawrence; Ganopolsky, Jorge Gabriel; Labbé, Alain; Wahl, Christopher; Prakash, Satya (2010-09-01). "Antimicrobial properties of nitric oxide and its application in antimicrobial formulations and medical devices". Applied Microbiology and Biotechnology. 88 (2): 401–407. doi:10.1007/s00253-010-2733-x. ISSN   0175-7598. PMID   20680266. S2CID   7018678.
  11. "'I don't smell!' Meet the people who have stopped washing". TheGuardian.com . 5 August 2019.
  12. Gormley, Brian (December 15, 2016). "AOBiome Stumbles Upon Blood-Pressure Target After Starting on Acne". Wall Street Journal. ISSN   0099-9660 . Retrieved June 14, 2017.